Impact of a VI-polysaccharide conjugate vaccine in preventing Typhoid Fever in an endemic setting, Lalitpur, Nepal
<p>Globally, an estimated 11 to 21 million cases of febrile illness and 117,000 to 161,000 deaths are attributed to typhoid fever each year. Typhoid fever is prevalent mainly in low-resource settings with poor water, and inadequate sanitation and hygiene facilities, with South Asia accounting...
المؤلف الرئيسي: | Shakya, M |
---|---|
مؤلفون آخرون: | Pollard, A |
التنسيق: | أطروحة |
اللغة: | English |
منشور في: |
2022
|
الموضوعات: |
مواد مشابهة
-
Cost-effectiveness analysis of typhoid conjugate vaccines in an outbreak setting: a modeling study
حسب: Maile T. Phillips, وآخرون
منشور في: (2023-03-01) -
Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: A randomized controlled phase 2 trial
حسب: Sodiomon B. Sirima, وآخرون
منشور في: (2021-07-01) -
Costs of typhoid vaccination for international travelers from the United States
حسب: Heesoo Joo, وآخرون
منشور في: (2025-03-01) -
Single and two-dose typhoid conjugate vaccine safety and immunogenicity in HIV-exposed uninfected and HIV-unexposed uninfected Malawian children
حسب: Nginache Nampota-Nkomba, وآخرون
منشور في: (2024-12-01) -
Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000 Salmonella Typhi genomes
حسب: Megan E Carey, وآخرون
منشور في: (2023-09-01)